Icon Advisers’s Boston Scientific BSX Stock Holding History

Icon Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-377,639	Closed	-$10.3M	–	302
2018 Q1	$10.3M	Sell	377,639 -92,200	-20%	-$2.51M	0.78%	37
2017 Q4	$11.6M	Buy	469,839 +173,139	+58%	+$4.78M	0.81%	34
2017 Q3	$8.65M	Buy	296,700 +52,100	+21%	+$1.44M	0.61%	42
2017 Q2	$6.78M	Sell	244,600 -30,400	-11%	-$807K	0.47%	69
2017 Q1	$6.84M	Sell	275,000 -74,500	-21%	-$1.81M	0.47%	65
2016 Q4	$7.56M	Buy	349,500 +245,500	+236%	+$5.36M	0.51%	60
2016 Q3	$2.48M	Buy	+104,000	New	+$2.48M	0.16%	181
2015 Q1	–	Sell	-74,000	Closed	-$980K	–	343
2014 Q4	$980K	Buy	+74,000	New	+$946K	0.06%	219
2014 Q3	–	Sell	-53,600	Closed	-$684K	–	324
2014 Q2	$684K	Buy	+53,600	New	+$697K	0.04%	251

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Icon Advisers's BSX Position: Q2 2018 in Review

Icon Advisers sold out of Boston Scientific (BSX) in Q2 2018, closing a stake of 377,639 shares — an estimated $10.3M sold.

Icon Advisers first reported a position in BSX in Q2 2014 and held it in 9 quarters. The position peaked at $11.6M in Q4 2017. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

Icon Advisers reported no remaining Boston Scientific position as of Q2 2018 after selling out during the quarter.
Icon Advisers sold 377,639 Boston Scientific shares in Q2 2018, an estimated $10.3M.
Icon Advisers first reported a position in Boston Scientific in Q2 2014 and held it in 9 quarters.
Icon Advisers's Boston Scientific position peaked at $11.6M in Q4 2017.
671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Icon Advisers's 13F filing for Q2 2018, filed 3 Aug 2018.